Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind,...

Area of Science:

• Gynecological Surgery
• Surgical Adhesions
• Medical Device Technology

Background:

• Post-surgical adhesions are a common complication of gynecological laparoscopy.
• Adhesions can lead to chronic pain, infertility, and bowel obstruction.
• Effective adhesion reduction strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To assess the efficacy and safety of Adept (4% icodextrin solution) for reducing adhesions.
• To compare Adept's performance against lactated Ringer's solution (LRS) in laparoscopic gynecological surgery.

Main Methods:

• A multicenter, prospective, randomized, double-blind study was conducted.
• 402 patients undergoing adhesiolysis were randomized to receive either Adept or LRS.
• Patients were reassessed via laparoscopy within 4-8 weeks to evaluate adhesion incidence, severity, and extent.

Main Results:

• A significantly higher rate of clinical success in adhesion treatment was observed with Adept (49%) compared to LRS (38%).
• Adept showed particular efficacy in infertility patients, with 55% achieving clinical success versus 33% for LRS.
• Adept use was associated with a greater reduction in American Fertility Society (AFS) scores and fewer patients in moderate/severe adhesion categories.

Conclusions:

• Adept is the first adhesion reduction agent validated in a randomized, double-blind trial for laparoscopic gynecological surgery.
• The study demonstrates Adept's safety and effectiveness in minimizing post-surgical adhesions.
• Adept offers a promising solution for improving outcomes in patients undergoing adhesiolysis.